17 hours ago

david 4.4k

@david_fe

Our recent discussion regarding The Gut–Eye Axis in Glaucoma: The Next Frontier generated a lively discussion (on the mailing list).

This is a follow-up post that continues to explore the growing body of peer-reviewed academic research that is shifting our gaze to the gut -- specifically the "Gut-Eye Axis." As discussed in the previous post, this biological highway connects our intestinal microbiome to our ocular health, suggesting that what we ingest may be just as critical as what we instill.

One ingredient leading this new frontier is EYEMUSE™ (specifically the strain Lacticaseibacillus paracasei KW3110). For pro-active eye health patients, particularly those managing conditions like digital eye strain or concerned about neuroprotection, understanding the science behind this specific immunobiotic offers a new, proactive tool for ocular wellness.

The Mechanism: How a "Paraprobiotic" Protects the Eye

To understand how a gut bacterium affects the eye, we must first clarify what EYEMUSE is. It is not a traditional live probiotic; it is a paraprobiotic (i.e., a heat-treated, stable microbial preparation), meaning the bacteria (L. paracasei KW3110) have been heat-treated.

Why does this matter?

1. Stability: Heat-treating renders the cells non-viable and can improve shelf-stability. Because the cells are not intended to be live, efficacy does not depend on surviving gastric acid as a viable organism.

2. Immune Modulation: Once in the gut, these particles interact with immune tissues (more broadly within the gut-associated immune system). Research shows they stimulate M2 macrophages, which are the "peacekeeper" immune cells, to produce Interleukin-10 (IL-10).

IL-10 is a powerful anti-inflammatory cytokine. A leading hypothesis is that this gut-driven immune signaling (including IL-10 pathways) can contribute to downstream anti-inflammatory effects relevant to retinal tissues. This systemic route is the key to how a capsule swallowed can support an eye strained by blue light.

The Clinical Evidence: Digital Eye Strain and Fatigue

The most robust human clinical data for this specific strain focuses on the modern plague of eye health: Digital Eye Strain (DES) in healthy adults exposed to visual display terminal (VDT) loads.

In randomized, double-blind, placebo-controlled trials, participants consuming L. paracasei KW3110 demonstrated improvements in objective and subjective measures associated with eye fatigue compared to the placebo group. In these studies, a key objective endpoint was critical flicker frequency (CFF), a commonly used proxy measure for eye fatigue; sample sizes were modest, and some outcomes were more apparent in higher-fatigue subgroups.

The mechanism appears to be the mitigation of blue light-induced inflammation in the retinal pigment epithelium (RPE) based on in-vitro work, where anti-inflammatory signaling helps buffer the retina against daily stress. By supporting resilience to this stress, the paraprobiotic may help maintain visual endurance and reduce the physical sensation of tired eyes (and, in some reports, associated symptoms such as stiff shoulders).

The Glaucoma Connection: Promising Pre-Clinical Data

For patients with glaucoma, the search for neuroprotection -- therapies that protect the optic nerve independent of lowering eye pressure -- is the "holy grail." While there are currently no human clinical trials confirming eye probiotic efficacy in glaucoma, academic research on this strain (L. paracasei KW3110) has shown promising potential in preclinical settings relevant to retinal aging and inflammation.

EYEMUSE is one of the few probiotic-derived (postbiotic) ingredients with placebo-controlled human trials specifically supporting eye health. Therefore, it caught my attention as something of interest to those of us living with glaucoma.

The Study: A pivotal study published in Aging (Albany NY) investigated the effects of long-term intake of L. paracasei KW3110 in aged mice.

Key Findings:

• Retinal Ganglion Cell (RGC) Preservation: Glaucoma is characterized by the death of RGCs. In the study, aged mice fed this specific paraprobiotic retained a significantly higher number of surviving RGCs compared to the control group. (Note: this was a physiologic aging model, not an induced glaucoma/ocular-hypertension model. But aging is the #1 risk factor for glaucoma.)

• Reduced Retinal Inflammation: The treatment suppressed the expression of pro-inflammatory cytokines in the retina. Chronic inflammation is increasingly recognized as a contributor to retinal degeneration and is also discussed in glaucoma pathophysiology.

• Mechanism: The protection was linked to the modification of the gut microbiota and the subsequent reduction of systemic inflammation, which typically accelerates retinal aging.

What this means for us: While we cannot yet claim this ingredient impacts glaucoma outcomes in humans, the data suggests it can act as a neuroprotective signal in the retina in an aging context. For a glaucoma patient, reducing systemic inflammation and supporting RGC resilience via the gut-eye axis represents a possible adjunctive strategy alongside standard pressure-lowering therapies and other lifestyle approaches.

Summary of Benefits

• Studied in peer-reviewed human trials (healthy adults) and preclinical models.
• Blue-light stress resilience: In vitro data suggest reduced inflammatory/oxidative stress responses in retinal pigment epithelium under blue-light-related conditions, consistent with anti-inflammatory signaling mechanisms.
• Neuroprotective potential: In aged mice, long-term intake was associated with less age-related retinal cell/RGC loss and lower retinal inflammatory signaling.
• Convenience: As a heat-treated paraprobiotic, it does not require refrigeration.

The Verdict

For the motivated patient, EYEMUSE represents a promising experimental approach to eye care. It moves beyond simple nutrition (like lutein or zeaxanthin) into the realm of immunomodulation via gut-immune signaling. While it should never replace prescribed glaucoma medications, its ability to regulate inflammation makes it a biologically plausible addition to a comprehensive eye health regimen.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your ophthalmologist before starting new supplements, especially if you are managing a condition like glaucoma.

References

1. From Gut to Eye: Exploring the Role of Microbiome Imbalance in Ocular Diseases. Tîrziu AT, Susan M, Susan R, et al. Journal of Clinical Medicine. 2024;13(18):5611. doi:10.3390/jcm13185611.
2. Targeting the Gut-Eye Axis: An Emerging Strategy to Face Ocular Diseases. Campagnoli LIM, Varesi A, Barbieri A, Marchesi N, Pascale A. International Journal of Molecular Sciences. 2023;24(17):13338. doi:10.3390/ijms241713338.
3. Influence of Gut Microbiota on Eye Diseases: An Overview. Napolitano P, Filippelli M, Davinelli S, et al. Annals of Medicine. 2021;53(1):750-761. doi:10.1080/07853890.2021.1925150.
4. A Review of the Impact of Alterations in Gut Microbiome on the Immunopathogenesis of Ocular Diseases. Bu Y, Chan YK, Wong HL, et al. Journal of Clinical Medicine. 2021;10(20):4694. doi:10.3390/jcm10204694.
5. The Gut-Eye Axis: The Retinal/Ocular Degenerative Diseases and the Emergent Therapeutic Strategies. Kammoun S, Rekik M, Dlensi A, et al. Frontiers in Cellular Neuroscience. 2024;18:1468187. doi:10.3389/fncel.2024.1468187.
6. Microbiome Signatures and Their Role in Uveitis: Pathogenesis, Diagnostics, and Therapeutic Perspectives. Agrawal K, Hong ASY, Cifuentes-González C, et al. Progress in Retinal and Eye Research. 2025;:101409. doi:10.1016/j.preteyeres.2025.101409.
7. Postbiotics and Paraprobiotics: From Concepts to Applications. Cuevas-González PF, Liceaga AM, Aguilar-Toalá JE. Food Research International (Ottawa, Ont.). 2020;136:109502. doi:10.1016/j.foodres.2020.109502.
8. Paraprobiotics: A New Perspective for Functional Foods and Nutraceuticals. Siciliano RA, Reale A, Mazzeo MF, et al. Nutrients. 2021;13(4):1225. doi:10.3390/nu13041225.
9. Postbiotics-Parabiotics: The New Horizons in Microbial Biotherapy and Functional Foods. Nataraj BH, Ali SA, Behare PV, Yadav H. Microbial Cell Factories. 2020;19(1):168. doi:10.1186/s12934-020-01426-w.
10. Postbiotics-a Step Beyond Pre- And Probiotics. Żółkiewicz J, Marzec A, Ruszczyński M, Feleszko W. Nutrients. 2020;12(8):E2189. doi:10.3390/nu12082189.
11. KW3110 Prevents Blue Light-Induced Inflammation and Degeneration in the Retina. Morita Y, Miwa Y, Jounai K, et al. Nutrients. 2018;10(12):E1991. doi:10.3390/nu10121991.
12. Lactic Acid Bacterium, Lactobacillus Paracasei KW3110, Suppresses Inflammatory Stress-Induced Caspase-1 Activation by Promoting Interleukin-10 Production in Mouse and Human Immune Cells. Yamazaki T, Ohshio K, Sugamata M, Morita Y. PloS One. 2020;15(8):e0237754. doi:10.1371/journal.pone.0237754.
13. Dectin-2 Mediates Phagocytosis of Lactobacillus Paracasei KW3110 and IL-10 Production by Macrophages. Yoshikawa M, Yamada S, Sugamata M, Kanauchi O, Morita Y. Scientific Reports. 2021;11(1):17737. doi:10.1038/s41598-021-97087-9.
14. Orally Administered Heat-Killed Lactobacillus Paracasei McC1849 Enhances Antigen-Specific IgA Secretion and Induces Follicular Helper T Cells in Mice. Arai S, Iwabuchi N, Takahashi S, et al. PloS One. 2018;13(6):e0199018. doi:10.1371/journal.pone.0199018.
15. Role of Lactobacillus Pentosus Strain B240 and the Toll-Like Receptor 2 Axis in Peyer's Patch Dendritic Cell-Mediated Immunoglobulin a Enhancement. Kotani Y, Kunisawa J, Suzuki Y, et al. PloS One. 2014;9(3):e91857. doi:10.1371/journal.pone.0091857.
16. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. Piqué N, Berlanga M, Miñana-Galbis D. International Journal of Molecular Sciences. 2019;20(10):E2534. doi:10.3390/ijms20102534.
17. Enhanced Immunomodulatory Activity and Stability in Simulated Digestive Juices of Lactobacillus Plantarum L-137 by Heat Treatment. Fujiki T, Hirose Y, Yamamoto Y, Murosaki S. Bioscience, Biotechnology, and Biochemistry. 2012;76(5):918-22. doi:10.1271/bbb.110919.
18. Heat-Killed Lactic Acid Bacteria Enhance Immunomodulatory Potential by Skewing the Immune Response Toward Th1 Polarization. Ou CC, Lin SL, Tsai JJ, Lin MY. Journal of Food Science. 2011 Jun-Jul;76(5):M260-7. doi:10.1111/j.1750-3841.2011.02161.x.
19. Effect of Heat-Killed Lactobacillus Paracasei KW3110 Ingestion on Ocular Disorders Caused by Visual Display Terminal (VDT) Loads: A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study. Morita Y, Jounai K, Miyake M, Inaba M, Kanauchi O. Nutrients. 2018;10(8):E1058. doi:10.3390/nu10081058.
20. KW3110 Suppresses Inflammatory Stress-Induced Premature Cellular Senescence of Human Retinal Pigment Epithelium Cells and Reduces Ocular Disorders in Healthy Humans. Yamazaki T, Suzuki H, Yamada S, et al. International Journal of Molecular Sciences. 2020;21(14):E5091. doi:10.3390/ijms21145091.
21. Blue Light-Induced Mitochondrial Oxidative Damage Underlay Retinal Pigment Epithelial Cell Apoptosis. Abdouh M, Chen Y, Goyeneche A, Burnier MN. International Journal of Molecular Sciences. 2024;25(23):12619. doi:10.3390/ijms252312619.
22. The Role of HMOX1-mediated Ferroptosis in Blue Light-Induced Damage to Retinal Pigment Epithelium. Ji C, Wang Y, Ju Y, et al. Scientific Reports. 2025;15(1):18949. doi:10.1038/s41598-025-03757-3.
23. Phototoxicity of Low Doses of Light and Influence of the Spectral Composition on Human RPE Cells. Françon A, Delaunay K, Jaworski T, et al. Scientific Reports. 2024;14(1):6839. doi:10.1038/s41598-024-56980-9.
24. The Role of Oxidative Stress and Autophagy in Blue-Light-Induced Damage to the Retinal Pigment Epithelium in Zebrafish in Vitro and in Vivo. Cheng KC, Hsu YT, Liu W, et al. International Journal of Molecular Sciences. 2021;22(3):1338. doi:10.3390/ijms22031338.
25. Blue Light-Induced Phototoxicity in Retinal Cells: Implications in Age-Related Macular Degeneration. Chakravarthy H, Georgyev V, Wagen C, Hosseini A, Matsubara J. Frontiers in Aging Neuroscience. 2024;16:1509434. doi:10.3389/fnagi.2024.1509434.
26. Filtering Blue Light Mitigates the Deleterious Effects Induced by the Oxidative Stress in Human Retinal Pigment Epithelial Cells. Abdouh M, Lu M, Chen Y, et al. Experimental Eye Research. 2022;217:108978. doi:10.1016/j.exer.2022.108978.
27. Long-Term Intake of KW3110 Prevents Age-Related Chronic Inflammation and Retinal Cell Loss in Physiologically Aged Mice. Morita Y, Jounai K, Sakamoto A, et al. Aging. 2018;10(10):2723-2740. doi:10.18632/aging.101583.